These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9721433)

  • 1. Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update.
    Trepanier DJ; Gallant H; Legatt DF; Yatscoff RW
    Clin Biochem; 1998 Jul; 31(5):345-51. PubMed ID: 9721433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of rapamycin.
    Yatscoff RW
    Transplant Proc; 1996 Apr; 28(2):970-3. PubMed ID: 8623483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.
    Yatscoff RW; Wang P; Chan K; Hicks D; Zimmerman J
    Ther Drug Monit; 1995 Dec; 17(6):666-71. PubMed ID: 8588238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model.
    Fryer J; Yatscoff RW; Pascoe EA; Thliveris J
    Transplantation; 1993 Feb; 55(2):340-5. PubMed ID: 8434385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus.
    MacDonald A; Scarola J; Burke JT; Zimmerman JJ
    Clin Ther; 2000; 22 Suppl B():B101-121. PubMed ID: 10823378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
    Yatscoff RW; LeGatt DF; Kneteman NM
    Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients.
    Kahan BD; Wong RL; Carter C; Katz SH; Von Fellenberg J; Van Buren CT; Appel-Dingemanse S
    Transplantation; 1999 Oct; 68(8):1100-6. PubMed ID: 10551636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolic disposition of sirolimus in healthy male volunteers after a single oral dose.
    Leung LY; Lim HK; Abell MW; Zimmerman JJ
    Ther Drug Monit; 2006 Feb; 28(1):51-61. PubMed ID: 16418694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.
    Kirchner GI; Winkler M; Mueller L; Vidal C; Jacobsen W; Franzke A; Wagner S; Blick S; Manns MP; Sewing KF
    Br J Clin Pharmacol; 2000 Nov; 50(5):449-54. PubMed ID: 11069439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of sirolimus.
    Mahalati K; Kahan BD
    Clin Pharmacokinet; 2001; 40(8):573-85. PubMed ID: 11523724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipients.
    Kelly PA; Napoli K; Kahan BD
    Biopharm Drug Dispos; 1999 Jul; 20(5):249-53. PubMed ID: 10594869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: interaction with cyclosporine.
    Serkova N; Hausen B; Berry GJ; Jacobsen W; Benet LZ; Morris RE; Christians U
    J Pharmacol Exp Ther; 2000 Jul; 294(1):323-32. PubMed ID: 10871329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
    Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
    Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood distribution of rapamycin.
    Yatscoff R; LeGatt D; Keenan R; Chackowsky P
    Transplantation; 1993 Nov; 56(5):1202-6. PubMed ID: 8249123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of everolimus.
    Kirchner GI; Meier-Wiedenbach I; Manns MP
    Clin Pharmacokinet; 2004; 43(2):83-95. PubMed ID: 14748618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus: the evidence for clinical pharmacokinetic monitoring.
    Stenton SB; Partovi N; Ensom MH
    Clin Pharmacokinet; 2005; 44(8):769-86. PubMed ID: 16029064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
    Hausen B; Ikonen T; Briffa N; Berry GJ; Christians U; Robbins RC; Hook L; Serkova N; Benet LZ; Schuler W; Morris RE
    Transplantation; 2000 Jan; 69(1):76-86. PubMed ID: 10653384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
    Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease.
    Lee C; Guo H; Klinngam W; Janga SR; Yarber F; Peddi S; Edman MC; Tiwari N; Liu S; Louie SG; Hamm-Alvarez SF; MacKay JA
    Mol Pharm; 2019 Jul; 16(7):3024-3039. PubMed ID: 31095909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.